MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 205 participants.

Also called NCT07874269

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 205 participants (planned count) (from the registry)
Sponsor
Jumraini Tammasse (from the registry)
Registry
  • NCT NCT07874269
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07874269. Randomized; double masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke
Intervention (Biological)
Mesenchymal Stem Cell-Derived Secretome
Intervention (Device)
Active Repetitive Transcranial Magnetic Stimulation
Intervention (Drug)
0.9% Sodium Chloride Placebo
Intervention (Device)
Sham Repetitive Transcranial Magnetic Stimulation
Lead sponsor
Jumraini Tammasse (class: other)

Record details

Record id
cardio:ct-nct07874269
Content hash
ccd4268999baee35938b2aa62e8a255171526302803a38571cc4d6d8c79a332e